BR0309101A - 1-oxa-3-aza-dibenzoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para sua produção - Google Patents

1-oxa-3-aza-dibenzoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para sua produção

Info

Publication number
BR0309101A
BR0309101A BR0309101-5A BR0309101A BR0309101A BR 0309101 A BR0309101 A BR 0309101A BR 0309101 A BR0309101 A BR 0309101A BR 0309101 A BR0309101 A BR 0309101A
Authority
BR
Brazil
Prior art keywords
production
aza
oxa
necrosis factor
tumor necrosis
Prior art date
Application number
BR0309101-5A
Other languages
English (en)
Inventor
Mladen Mercep
Milan Mesic
Dijana Pesic
Iva Benko
Original Assignee
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Inst D O O filed Critical Pliva Istrazivacki Inst D O O
Publication of BR0309101A publication Critical patent/BR0309101A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"1-OXA-3-AZA-DIBENZOAZULENOS COMO INIBIDORES DE PRODUçãO DE FATOR DE NECROSE DE TUMOR E INTERMEDIáRIOS PARA SUA PRODUçãO". A presente invenção refere-se a derivados da classe dos 1-oxa-3-aza-dibenzoazulenos, a seus sais e solvatos farmacologicamente aceitáveis, a processos e intermediários para sua preparação bem como a suas ações antiinflamatórias, especialmente para a inibição da produção de fator<244> de necrose de tumor (TNF-<244>) e para a inibição da produção de interleucina-1 (IL-1) bem como à sua ação analgética.
BR0309101-5A 2002-04-10 2003-04-09 1-oxa-3-aza-dibenzoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para sua produção BR0309101A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20020304A HRP20020304B1 (en) 2002-04-10 2002-04-10 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
PCT/HR2003/000015 WO2003084964A1 (en) 2002-04-10 2003-04-09 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof

Publications (1)

Publication Number Publication Date
BR0309101A true BR0309101A (pt) 2005-02-09

Family

ID=28686902

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309101-5A BR0309101A (pt) 2002-04-10 2003-04-09 1-oxa-3-aza-dibenzoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para sua produção

Country Status (23)

Country Link
US (1) US7232815B2 (pt)
EP (1) EP1492797B1 (pt)
JP (1) JP2005529867A (pt)
CN (1) CN1649878A (pt)
AT (1) ATE320434T1 (pt)
AU (1) AU2003259960A1 (pt)
BR (1) BR0309101A (pt)
CA (1) CA2481463A1 (pt)
DE (1) DE60304047T2 (pt)
DK (1) DK1492797T3 (pt)
ES (1) ES2260636T3 (pt)
HR (1) HRP20020304B1 (pt)
IL (1) IL164397A0 (pt)
IS (1) IS7473A (pt)
MX (1) MXPA04009944A (pt)
NO (1) NO20044507L (pt)
NZ (1) NZ535621A (pt)
PL (1) PL372456A1 (pt)
PT (1) PT1492797E (pt)
RU (1) RU2323222C2 (pt)
UA (1) UA79276C2 (pt)
WO (1) WO2003084964A1 (pt)
YU (1) YU88204A (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
DE10256416A1 (de) * 2002-12-02 2004-06-09 Basf Ag Feste Pigmentzubereitungen, enthaltend Pigmentderivate und oberflächenaktive Additive
HRP20030959A2 (pt) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o.
JP2008532927A (ja) * 2005-01-13 2008-08-21 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症マクロライド接合体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745167A (en) * 1968-03-19 1973-07-10 Hoffmann La Roche 3a,12b-dihydro-8h-dibenzo(3,4,6,7)cyclohept(1,2,-)oxazol-8-ones and processes for their preparation
JPS458611Y1 (pt) 1969-08-18 1970-04-22
GB1340637A (en) * 1971-02-05 1973-12-12 Richardson Merrell Spa Dibenzocycloheptadioxolan derivatives
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
CA967573A (en) 1972-12-22 1975-05-13 Joseph G. Lombardino Tetracyclic anti-inflammatory agents
US4198421A (en) 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
PT789702E (pt) * 1994-11-02 2001-07-31 Janssen Pharmaceutica N V Jans Derivados de oxazepina e tiazepina tetraciclicos substituidos com afinidade para receptores 5-ht2
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020305A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020303A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
US20050131056A1 (en) * 2002-04-10 2005-06-16 Pliva-Istrazivacki Institut D.O.O. 2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020453A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS

Also Published As

Publication number Publication date
RU2004132867A (ru) 2005-05-10
NO20044507L (no) 2004-11-09
IS7473A (is) 2004-09-27
US20050148576A1 (en) 2005-07-07
CA2481463A1 (en) 2003-10-16
PL372456A1 (en) 2005-07-25
EP1492797A1 (en) 2005-01-05
DK1492797T3 (da) 2006-07-17
US7232815B2 (en) 2007-06-19
HRP20020304A2 (en) 2004-06-30
AU2003259960A1 (en) 2003-10-20
RU2323222C2 (ru) 2008-04-27
DE60304047D1 (de) 2006-05-11
PT1492797E (pt) 2006-07-31
CN1649878A (zh) 2005-08-03
ES2260636T3 (es) 2006-11-01
MXPA04009944A (es) 2005-09-30
JP2005529867A (ja) 2005-10-06
UA79276C2 (en) 2007-06-11
EP1492797B1 (en) 2006-03-15
ATE320434T1 (de) 2006-04-15
HRP20020304B1 (en) 2008-04-30
WO2003084964A1 (en) 2003-10-16
IL164397A0 (en) 2005-12-18
NZ535621A (en) 2006-03-31
DE60304047T2 (de) 2006-11-09
YU88204A (sh) 2006-08-17

Similar Documents

Publication Publication Date Title
BR0212014A (pt) Uso de derivados do ácido hidroxâmico inibidores da enzima histone deacetilase
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
CY1109328T1 (el) Ενωσεις θειενοδιβενζοαζουλενιου ως αναστολεις παραγοντα νεκρωσης ογκου
HN2002000156A (es) Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
AU4888401A (en) Sulfonamide derivative as a matrix metalloproteinase inhibitor
UY28310A1 (es) Pirazoles como inhibidores de factor de necrosis tumoral
BR0311767A (pt) Compostos inibidores de sulfonamida substituìda da produção de beta amilóide, suas composições e usos
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
DE602005011452D1 (de) Zur behandlung von entzündungen geeignete indole
BRPI0507052A (pt) inibidores de quìnase
BR0214672A (pt) Inibidores de fosfolipase citosólica a2
BR0309094A (pt) 2-tia-dibenzoazulenos como inibidores da produção do fator de necrose de tumor e intermediários para a preparação dos mesmos
BR0309097A (pt) Benzonaftoazulenos como inibidores de produção de fator de necrose de tumor e intermediários para a sua preparação
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
WO2003099823A3 (en) 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
BRPI0514843A (pt) derivados de pirrolo[3,2-c] piridina e processos para a preparação dos mesmos
WO2003097649A3 (en) 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
YU88204A (sh) 1-oksa 3-aza-dibenzoazuleni kao inhibitori stvaranja faktora tumorske nekroze i međuproizvodi za njihovo pripremanje
DE602005014233D1 (de) Zur behandlung von entzündungen geeignete indole
WO2003099822A3 (en) 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
UA84544C2 (ru) Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида
GT199900178A (es) Metodo para utilizar inhibidores de la enzima ciclooxigenasa-2 en la prevencion de trastornos cardiovasculares.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07D 495/04, A61K 31/38, A61P 29/00

Ipc: C07D 498/04 (2011.01), A61K 31/42 (2011.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE A 8.6 DA RPI 2116 DE 26/07/2011.